Experiences from IP directors in Big Pharma transactions
- Decode Genetics being acquired by Big Pharma (Amgen)
- Big Pharma thinking in mergers and acquisitions
Hands-on experience from both sides. Learn about setting up your IP strategy to improve exit potential.
Thorlakur Jonsson was IP director at Decode Genetics and will talk about his experience of the company being acquired by Big Pharma (Amgen).
Marie Mannerlöf (formerly Tenning) joined KIPA recently from an in-house IP director position at Johnson & Johnson. Marie will talk about Big Pharma and her experience in evaluating start-ups for mergers and acquisitions.
KIPA is an expert IPR Company with deep expertise in Life Science and Medical Devices. Successfully transform an idea into a product on various markets with different legal environments. We will help you avoid traps in the IP jungle and build a company with a robust legal portfolio before exit.
Please register no later than Monday 17 April 2023